SWOT Analysis of AstraZeneca

SWOT analysis of AstraZenecaStrengthsAstraZeneca?s key products were Crestor, Nexium, Seroquel, Arimidex, Pulmicort, Symbicort in 2007 annual Report. The sales of Crestor, Merrem, Seroquel increased significantly in 2007 but the contemporary block-busters of the sozzled is Nexium. The high society has strong focus on investigate and schooling; it employs 13,000 people at its research facilities, furthermore do acquisitions tie in to R&D by purchasing praise P harmaceuticals, Cambridge Antibody, Medimmune and Arrow Therapeutics. By lay emphasis on dose research, the company invests into the future in request to find tender components. Due to the strong pecuniary performance of the company it is fitting to provide the financial resources obligatory for developing impertinently medicines and investments need to reach new commercialises. WeaknessesPatent ProtectionAs the conspicuous protection of actual sorcerer products expire they must be replaced by new deve lopments to exercise the high revenue of the firm. AstraZeneca?s need for new components deform to retain and increase its market share and competitiveness. Legal casesAstraZeneca has been fined ?60 million by the European Commission for manipulating procure laws to lionise competitors out of the market, marking the firstborn occasion that antitrust laws cast been used to combat patent abuse (in-pharmatechnologist.com n.d.). The firm must be prepared to cover up legal questions, such as: outcomes of litigations or difficulties in obtaining and maintaining regulatory approvals for new products.

There be in possession of been legion(predicate) patent protection litigations in the US ; Seroquel, omeprazole or Crestor in 2007 wh! en AstraZeneca filed patent infringement suits against seven companies that submitted foreshorten new drug applications (ANDAs) seeking to market generic versions of its cholesterol drug before the patents expire. Unlucky outcome of government investigations could harm the company?s prestige, as it happened in 2003 when AstraZeneca admitted to criminal crew to fall apart the Prescription Drug Marketing Act in the US. insulation of new developmentsDevelopment of... If you want to get a safe essay, order it on our website: OrderEssay.net

If you want to get a full information about our service, visit our page: How it works.